Core Viewpoint - Quantitative strategy funds are experiencing a remarkable resurgence amidst the wave of innovative drugs dominating the market, with nearly 100 funds reaching historical net asset value highs this year [1][2]. Group 1: Performance of Quantitative Strategy Funds - Nearly 100 quantitative strategy funds have achieved historical net asset value highs, with some funds, where the top ten holdings account for less than 6% of stock holdings, generating nearly 50% returns this year [2][5]. - Notable funds such as Nuon Multi-Strategy, CCB Flexible Allocation, and CITIC Prudential Multi-Strategy have recently set new historical net values, showcasing the effectiveness of quantitative strategies [5][6]. - The average return of public quantitative funds this year is 11.21%, with 95.86% of these funds achieving positive returns, indicating a strong recovery in the performance of active quantitative funds [7]. Group 2: Market Environment and Strategy Evolution - The improved market environment has provided an ideal stage for quantitative strategies, with factors like beta, momentum, and leverage showing significant gains [8][9]. - The average daily trading volume of A-shares has remained above 1 trillion yuan, enhancing market activity and optimizing trading conditions for quantitative models [9]. - The performance of small-cap stocks has significantly contributed to the returns of quantitative strategies, with the Wind Micro-Cap Index rising over 43% this year [11]. Group 3: Investment Strategies and Risk Management - Fund managers are increasingly focusing on enhancing performance stability and adapting their models to market changes, with some funds adjusting their strategies to include a more balanced allocation between small and large-cap stocks [12][13]. - The strategy of "picking up cigarette butts" in undervalued small-cap stocks has yielded a 48.24% positive return for Nuon Multi-Strategy this year, demonstrating the potential of this approach [6][12]. - Fund managers are cautious about the risks associated with small-cap stocks, with discussions around the potential overheating of small-cap strategies becoming more prevalent [14][16].

Core Viewpoint - Under the backdrop of normalized global geopolitical risks, weakened dollar credit system, and rising economic uncertainty, gold has emerged as a "yardstick" for measuring asset value [1] Asset Performance - Since March 2018, only a few cryptocurrencies have recorded positive returns when priced in gold, while other asset classes have generally underperformed [2] - The report highlights that the performance of cryptocurrencies is driven by payment convenience, technological innovation premiums, and supply scarcity, particularly Bitcoin's halving mechanism, which reinforces its "digital gold" status [4] - Equity assets have shown nominal growth but remain weak when priced in gold, primarily relying on liquidity injections, with a peak growth rate of 26.7% in the US M2 money supply [4] - Real estate in the US and India has underperformed relative to gold, despite benefiting from economic resilience and demographic dividends [4] Industry Performance - All major industries have underperformed gold since 2018, but resource sectors and new momentum industries, such as high-dividend coal and banking, have shown relative strength [6] - New momentum industries, represented by electric new energy and TMT, have outperformed traditional sectors like real estate [7] - In the secondary industry, precious metals have been the standout performer since 2018, with emerging technologies like semiconductors outperforming traditional tech [8] Style and Strategy - Small-cap stocks have emerged as the absolute winners, with the micro-cap index outperforming gold since 2018 due to a reverse investment mechanism, low valuations, and liquidity premiums [10][13] - The report indicates that small-cap factors have significantly outperformed gold, while large-cap stocks have lagged, reflecting a preference for emerging small-cap industries [14]

Core Viewpoint - The article highlights the increasing popularity of dividend-paying assets in the market, with A-shares expected to distribute over 2.39 trillion yuan in dividends in 2024, setting a new historical record. The focus is on the dividend distribution of private equity funds in 2024, with 23.36% of the analyzed products expected to pay dividends [2][3]. Summary by Category Private Equity Fund Dividend Distribution - Among 3938 private equity products with performance data, 920 are expected to distribute dividends in 2024, representing 23.36% of the total [2]. - The leading private equity firm in terms of the number of dividend-paying products is Junfu Investment, with 17 products expected to pay dividends in 2024 [2][3]. Performance of Dividend-Paying Products - Continuous dividends indicate strong profit-generating capabilities, with only 14 products having paid dividends for five consecutive years, showcasing impressive performance [4]. - The average return for private equity products that will distribute dividends in 2024 varies by fund size, with notable performances in different categories [6][12][15]. Performance by Fund Size - **100 Billion+ Yuan Private Equity**: 13.75% of products are expected to pay dividends, with an average return of 21.05% for these products [6][7]. - **50-100 Billion Yuan Private Equity**: 16.17% of products are expected to pay dividends, with an average return of 15.33% [10]. - **20-50 Billion Yuan Private Equity**: 35.96% of products are expected to pay dividends, with an average return of 18.22% [12][13]. - **10-20 Billion Yuan Private Equity**: 24.46% of products are expected to pay dividends, with an average return of 21.66% [15][16]. - **5-10 Billion Yuan Private Equity**: 26.83% of products are expected to pay dividends, with an average return of 20.03% [19][20]. - **0-5 Billion Yuan Private Equity**: 25.39% of products are expected to pay dividends, with an average return of 25.58% [22]. Notable Products and Managers - Junfu Investment's "Junfu Gold Enhanced No. 2" achieved a return of ***% in 2024 and paid dividends twice, leading in the 20-50 billion yuan category [12][14]. - The top-performing product in the 100 billion+ category is "Yanfeng Exclusive Small Cap Index Enhanced No. 1" from Yanfeng Investment, with a return of ***% [8][9]. - In the 50-100 billion category, "Square and Ding Sheng Zhong Zheng 2000 Index Enhanced No. 21A" from Square and Investment paid dividends twice and achieved a return of ***% [10][11].